Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

INTRODUCTION: We compared the economic impacts of linezolid and vancomycin for the treatment of hospitalized patients with methicillin-resistant Staphylococcus aureus (MRSA)–confirmed nosocomial pneumonia. METHODS: We used a 4-week decision tree model incorporating published data and expert opinion...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Crit Care
Главные авторы: Patel, Dipen A, Shorr, Andrew F, Chastre, Jean, Niederman, Michael, Simor, Andrew, Stephens, Jennifer M, Charbonneau, Claudie, Gao, Xin, Nathwani, Dilip
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4220084/
https://ncbi.nlm.nih.gov/pubmed/25053453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc13996
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы